Trial Profile
Haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide in combination with thymoglobulin (RIC version) Phase I
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2018
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Cyclophosphamide (Primary) ; Antineoplastics
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Therapeutic Use
- Acronyms Post-haploSCT CY
- 31 Oct 2018 Status changed from recruiting to completed.
- 09 Jul 2013 New trial record